Diana Kerwin - Concepedia

Author

Diana Kerwin

Also Known As

Andrew Keegan, Borna Bonakdarpour, Charles Bernick, Chuang-Kuo, Clifford R Jack, D. Kerwin, D. R. Kerwin, D.R. Kerwin,, David S. Knopman, Delwyn D. Miller

171

Publications

13.4K

Citations

H-Index

Concepts

All Affiliations

Northwestern University The University of Texas Southwestern Medical Center Washington University in St. Louis University of California, Los Angeles University of Pennsylvania

About

Diana Kerwin is an author at Northwestern University specializing in medicine, neurology, and cerebral blood flow.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	764
2	Health Sciences	4	4	199
3	Social Sciences	2	2	78
4	Engineering	1	1	45
5	Emergency Medicine	1	1	148

Diana Kerwin

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial Adam L. Boxer, David S. Knopman, Daniel Kaufer, The Lancet Neurology Frontotemporal Lobar DegenerationClinical TrialsFrontotemporal DementiaPlacebo-controlled TrialPharmacotherapy	2013	217
Utility of the global CDR<sup>®</sup> plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium Toji Miyagawa, Danielle Brushaber, Jeremy A. Syrjanen, Alzheimer s & Dementia	2020	155
Vascular burden and Alzheimer disease pathologic progression Raymond Y. Lo, William J. Jagust, Michael W. Weiner, Neurology	2012	153
Prevalence and significance of unrecognized lower extremity peripheral arterial disease in general medicine practice Mary Mcdermott, Diana Kerwin, Kiang Liu, Journal of General Internal Medicine Cardiovascular DiseaseGeneral Medicine PracticeVascular SurgeryArterial DiseaseMedicine	2001	148
Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients With Late-Life Depression Junhao Wen, Cynthia H.Y. Fu, Duygu Tosun, JAMA Psychiatry	2022	134
Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial Günter U. Höglinger, Irene Litvan, Nuno Mendonça, The Lancet Neurology Clinical TrialsProgressive Supranuclear PalsyPlacebo-controlled TrialPharmacotherapyPain Management	2021	130
Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration Julio C. Rojas, Ping Wang, Adam M. Staffaroni, Neurology	2021	101
Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy Kiran Yanamandra, Tirth K. Patel, Hong Jiang, Science Translational Medicine	2017	98
Interaction Between Body Mass Index and Central Adiposity and Risk of Incident Cognitive Impairment and Dementia: Results from the Women's Health Initiative Memory Study Diana Kerwin, Sarah A. Gaussoin, Rowan T. Chlebowski, Journal of the American Geriatrics Society	2011	93
Exercise Training in Amnestic Mild Cognitive Impairment: A One-Year Randomized Controlled Trial Takashi Tarumi, Heidi Rossetti, Binu P. Thomas, Journal of Alzheimer s Disease	2019	83

Page 1